Latest Data & Signals Issued

Below are some of the latest signals issued for Compass Pathways PLC

General

Signal Type Signal Value Data
Score 3.097 34 days ( -90.54 %
Last Price $12.69 -4.80 %
Performance History
7 Days
$11.85 $12.69
7.09%
30 Days
$9.52 $12.69
33.30%
12 Mos
$4.59 $12.69
176.47%

11/18

Active Buy Signals

Specific Signals

Short Term
Net score: 61.54
Signal Type Signal Value Importance Data
High / Low Buy Very Low $12.50 - $13.36
Position: 22.09% from low / 77.91% from high · Momentum: 36.55%
Trend - 3 mos 105.30 % High Width: 46.29 %
Pred. range - 3 mos $20.24 - $29.61 Low 59.52 % - 133.36 %
Volume Direction Sell High Volume: 4,686,894 · Direction: 0
Pivot Short Sell Very Low Jun 01, 2026 - 3 days
RSI Short Pivot Signal Sell Very Low Jun 01, 2026 - 3 days
Short MA 3 mos Sell Low Jun 02, 2026 - 2 days
Long MA 3 mos Buy Medium Apr 15, 2026 - 35 days
Short/Long MA 3 mos Buy Medium Apr 17, 2026 - 33 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 83.07
Signal Type Signal Value Importance Data
Trend - 12 mos 65.27 % Very High Width: 127.69 %
Pred. range - 12 mos $10.33 - $23.53 High -18.58 % - 85.39 %
Short MA 12 mos Buy Very High Apr 10, 2026 - 38 days
Long MA 12 mos Buy Very High Apr 15, 2026 - 35 days
Short/Long MA 12 mos Buy Very High Apr 24, 2026 - 28 days
Pivot Long Sell Low Jun 01, 2026 - 3 days
RSI Long Pivot Signal Sell Low Jun 01, 2026 - 3 days
Bollinger Buy Medium Apr 16, 2026 - 34 days
MACD Buy High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT COMPASS PATHWAYS PLC
Compass Pathways
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in Augu...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE